{"id":28806,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"de-noodzaak-voor-vergoeding-van-biologicals","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/","title":{"rendered":"De noodzaak voor vergoeding van biologicals"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1473 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Brussel 2018<\/h2>\n<p>Een zeer belangrijke aflevering van debatten over biologicals en de noodzaak voor vergoeding. Alle panelleden bespreken de kwestie vanuit het oogpunt van medische en gezondheidsautoriteiten. Artsen delen hun mening over innovatieve behandelingen en leggen uit hoeveel fasen de huidige onderzoeken omvatten en hoe deze informatie kan worden gebruikt als economisch argument met betrekking tot de werkzaamheid voor pati\u00ebnten en de verbetering van de levenskwaliteit, maar ook om de algemene kosten van de ziekte te verlagen.  <\/p>\n<h3>Panelleden<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, pati\u00ebntvertegenwoordigers.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1474 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/ibJ8ZcNGvXk?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Brussel 2018 Een zeer belangrijke aflevering van debatten over biologicals en de noodzaak voor vergoeding. Alle panelleden bespreken de kwestie vanuit het oogpunt van medische en gezondheidsautoriteiten. Artsen delen hun mening over innovatieve behandelingen en leggen uit hoeveel fasen de huidige onderzoeken omvatten en hoe deze informatie kan worden gebruikt als economisch argument met betrekking tot de werkzaamheid voor pati\u00ebnten en de verbetering van de levenskwaliteit, maar ook om de algemene kosten van de ziekte te verlagen. Panelleden Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, pati\u00ebntvertegenwoordigers.<\/p>\n","protected":false},"author":1,"featured_media":28816,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[233],"tags":[234,235,236,154,181],"class_list":["post-28806","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-rhinologie","tag-debatten","tag-rhinology-future-debates","tag-zorgverleners","tag-biologicals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>De noodzaak voor vergoeding van biologicals - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De noodzaak voor vergoeding van biologicals\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Brussel 2018 Een zeer belangrijke aflevering van debatten over biologicals en de noodzaak voor vergoeding. Alle panelleden bespreken de kwestie vanuit het oogpunt van medische en gezondheidsautoriteiten. Artsen delen hun mening over innovatieve behandelingen en leggen uit hoeveel fasen de huidige onderzoeken omvatten en hoe deze informatie kan worden gebruikt als economisch argument met betrekking tot de werkzaamheid voor pati\u00ebnten en de verbetering van de levenskwaliteit, maar ook om de algemene kosten van de ziekte te verlagen. Panelleden Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, pati\u00ebntvertegenwoordigers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/\",\"name\":\"De noodzaak voor vergoeding van biologicals - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_18.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/de-noodzaak-voor-vergoeding-van-biologicals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"De noodzaak voor vergoeding van biologicals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"De noodzaak voor vergoeding van biologicals - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/","og_locale":"nl_NL","og_type":"article","og_title":"De noodzaak voor vergoeding van biologicals","og_description":"Rhinology Future Debates Brussel 2018 Een zeer belangrijke aflevering van debatten over biologicals en de noodzaak voor vergoeding. Alle panelleden bespreken de kwestie vanuit het oogpunt van medische en gezondheidsautoriteiten. Artsen delen hun mening over innovatieve behandelingen en leggen uit hoeveel fasen de huidige onderzoeken omvatten en hoe deze informatie kan worden gebruikt als economisch argument met betrekking tot de werkzaamheid voor pati\u00ebnten en de verbetering van de levenskwaliteit, maar ook om de algemene kosten van de ziekte te verlagen. Panelleden Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, pati\u00ebntvertegenwoordigers.","og_url":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/","url":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/","name":"De noodzaak voor vergoeding van biologicals - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_18.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/de-noodzaak-voor-vergoeding-van-biologicals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/nl\/news\/"},{"@type":"ListItem","position":3,"name":"De noodzaak voor vergoeding van biologicals"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/nl\/#website","url":"https:\/\/www.euforea.org\/nl\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/nl\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/28806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=28806"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/28806\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/28816"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=28806"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=28806"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=28806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}